Back to mobile site

Citi Opens 90-Day Upside Catalyst Watch on Kymera Therapeutics (KYMR)

October 5, 2026 5:24 AM EDT Send to a Friend
Citi analyst Geoff Meacham reiterated a Buy rating and $150.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login